UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
American journal of obstetrics and gynecology, ISSN 0002-9378, 2017, Volume 216, Issue 6, pp. 586.e1 - 586.e6
Obstetrics and Gynecology | effectiveness | prolonged use | implant | intrauterine device | Food and Drug Administrationāapproved duration | Body Mass Index | Prospective Studies | Desogestrel - adverse effects | United States | Humans | Middle Aged | Drug Implants | Intrauterine Devices, Medicated | Pregnancy | Young Adult | Desogestrel - administration & dosage | Time Factors | Levonorgestrel - administration & dosage | Levonorgestrel - adverse effects | Pregnancy, Unplanned | Adolescent | Adult | Female | Contraceptive Agents, Female | United States Food and Drug Administration | Cohort Studies | Contraceptive drug implants | Medical colleges | Medical research | Usage | Analysis | Levonorgestrel | Medicine, Experimental | Index Medicus | Abridged Index Medicus
Journal Article
Obstetrics and gynecology (New York. 1953), ISSN 0029-7844, 03/2015, Volume 125, Issue 3, pp. 599 - 604
Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Prospective Studies | United States | Humans | Contraceptive Agents, Female - administration & dosage | Intrauterine Devices, Medicated | Young Adult | Desogestrel - administration & dosage | Time Factors | Levonorgestrel - administration & dosage | Adolescent | Adult | Female | United States Food and Drug Administration | Index Medicus | Abridged Index Medicus
Journal Article
Journal of controlled release, ISSN 0168-3659, 09/2015, Volume 213, pp. 57 - 68
Efficacy | Coreāmatrix design | Contraception | Multipurpose prevention technology | Microbicides | Intravaginal ring | Core-matrix design | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Contraceptive Agents, Female - pharmacology | HIV Infections - prevention & control | Drug Delivery Systems - instrumentation | Antiviral Agents - pharmacokinetics | Urea - pharmacokinetics | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Contraceptive Agents, Female - administration & dosage | Pyridines - pharmacokinetics | Administration, Intravaginal | Human papillomavirus 16 - drug effects | Macaca mulatta | Equipment Design | Herpes Genitalis - prevention & control | Levonorgestrel - pharmacokinetics | Carrageenan - pharmacology | Urea - analogs & derivatives | Zinc Acetate - administration & dosage | Contraceptive Agents, Female - pharmacokinetics | Female | Herpesvirus 2, Human - drug effects | Urea - administration & dosage | Cell Line | Antiviral Agents - pharmacology | Levonorgestrel - pharmacology | Pyridines - administration & dosage | HIV-1 - drug effects | Carrageenan - pharmacokinetics | Contraceptive Devices, Female - virology | Antiviral Agents - administration & dosage | Pregnancy | Animals | Levonorgestrel - administration & dosage | Papillomavirus Infections - prevention & control | Zinc Acetate - pharmacokinetics | Zinc Acetate - pharmacology | Pyridines - pharmacology | HeLa Cells | Urea - pharmacology | Carrageenan - administration & dosage | Prevention | Contraceptives | Carrageenin | Pregnant women | Elastomers | Liquefied natural gas | HIV (Viruses) | Warships | Index Medicus | intravaginal ring | multipurpose prevention technology | core-matrix design | contraception | microbicides | efficacy
Journal Article
Best practice & research. Clinical obstetrics & gynaecology, ISSN 1521-6934, 2014, Volume 28, Issue 6, pp. 845 - 857
Obstetrics and Gynecology | spermatogenesis | testis | testosterone | contraception | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Oligospermia - chemically induced | Sperm Count | Antispermatogenic Agents - administration & dosage | Humans | Drug Implants | Male | Administration, Cutaneous | Testosterone - analogs & derivatives | Contraceptives, Oral, Synthetic - administration & dosage | Estrenes - administration & dosage | Adamantane - administration & dosage | Adamantane - analogs & derivatives | Azoospermia - chemically induced | Contraception - methods | Gels - administration & dosage | Clinical Trials as Topic | Injections, Intramuscular | Evidence-Based Medicine | Androgens - administration & dosage | Contraceptive Agents, Male - administration & dosage | Desogestrel - administration & dosage | Testosterone - administration & dosage | Animals | Vasectomy | Levonorgestrel - administration & dosage | Progestins - administration & dosage | Analysis | Contraception | Index Medicus
Journal Article
Biomedical chromatography, ISSN 0269-3879, 12/2018, Volume 32, Issue 12, pp. e4367 - n/a
intravaginal ring | pharmacokinetic | LCāMS/MS | levonorgestrel | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Pharmacology & Pharmacy | Chemistry, Analytical | Science & Technology | Reproducibility of Results | Chromatography, High Pressure Liquid - methods | Drug Stability | Contraceptive Devices, Female | Administration, Intravaginal | Linear Models | Animals | Levonorgestrel - pharmacokinetics | Levonorgestrel - administration & dosage | Levonorgestrel - blood | Sensitivity and Specificity | Dogs | Female | Tandem Mass Spectrometry - methods | Contraceptive drug implants | Liquefied natural gas | Mass spectrometry | Analysis | High performance liquid chromatography | Levonorgestrel | Index Medicus
Journal Article
Cochrane database of systematic reviews, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, pp. CD001324 - CD001324
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Norpregnadienes - adverse effects | Drug Administration Schedule | Intrauterine Devices, Copper - adverse effects | Contraceptives, Postcoital - adverse effects | Contraception, Postcoital - adverse effects | Humans | Estradiol - administration & dosage | Intrauterine Devices, Medicated - adverse effects | Norpregnadienes - administration & dosage | Randomized Controlled Trials as Topic | Pregnancy | Mifepristone - adverse effects | Levonorgestrel - administration & dosage | Levonorgestrel - adverse effects | Contraceptives, Postcoital - administration & dosage | Unsafe Sex | Estradiol - adverse effects | Female | Contraception, Postcoital - methods | Pregnancy Rate | Mifepristone - administration & dosage | Index Medicus
Journal Article
Cochrane library, 11/2020, Volume 2020, Issue 11, pp. CD008994 - CD008994
Leiomyoma | OTHER ENDOCRINE DISORDERS (E.G. CONGENITAL ADRENAL HYPERPLASIA) | Antineoplastic Agents, Hormonal | Menstruation | Premenopause | Leuprolide | Levonorgestrel | Fibroids | Tumor Burden | Intrauterine Devices, Medicated | Randomized Controlled Trials as Topic | Gynaecology | Uterine Neoplasms | Menstrual cycle disorders/oligo-amenorrhoea | Progestins | DISORDERS OF MENSTRUAL CYCLING / OLIGO-AMENORRHOEA IN ASSOCIATION WITH | Medroxyprogesterone Acetate | Medicine General & Introductory Medical Sciences | Infertility/subfertility | Lynestrenol | Reproductive & sexual health | Other | Uterine Neoplasms - pathology | Bias | Humans | Middle Aged | Leiomyoma - pathology | Menstruation - drug effects | Leuprolide - administration & dosage | Contraceptives, Oral - administration & dosage | Adult | Female | Norethindrone Acetate - administration & dosage | Goserelin - administration & dosage | Nandrolone - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Nandrolone - analogs & derivatives | Lynestrenol - administration & dosage | Desogestrel - administration & dosage | Tumor Burden - drug effects | Levonorgestrel - administration & dosage | Progestins - administration & dosage | Leiomyoma - drug therapy | Uterine Neoplasms - drug therapy | Medroxyprogesterone Acetate - administration & dosage | Index Medicus
Journal Article